FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
STERIS plc Stock AnalysisComprehensive stock analysis for STERIS plc (STE) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSTE
STE
STERIS plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
STE
Home🔹Stocks🔹STERIS plc

STERIS plc

🇺🇸STE•NYSE

STERIS plc

🇺🇸STE•NYSE
Market cap
$20.54B
Sentiment

Your view on STE

Mkt Cap
$20.54B
Sentiment
Your view
STE
STERIS plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
STE
Company Overview

Overview

What the company does, where it operates, and who runs it.

About STERIS plc

Industry
Medical - Specialties
Sector
Healthcare
CEO
Daniel A. Carestio
Headquarters
70 Sir John Rogerson's Quay, Dublin, IE
Industry
Medical - Specialties
Sector
Healthcare
CEO
Daniel A. Carestio
Headquarters
70 Sir John Rogerson's Quay, Dublin, IE
Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.

The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.

The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities.

The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors.

This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite.

The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for STERIS plc, and the rating behind it. STE last traded at $210.76, 25.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for STERIS plc. Starting points for STERIS plc: P/E 25.8, EPS $8.25, beta 0.91 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for STERIS plc. STERIS plc paid $2.58 per share over the last year — a 1.2% yield at the current $210.76 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for STERIS plc. Trailing twelve-month EPS for STERIS plc stands at $8.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for STERIS plc. STERIS plc has reported as a listed company since 1992. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

STERIS plc valued side by side against its closest peers. STERIS plc is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold STERIS plc, and how their positions are changing. At a $20.54B market value, institutional positions materially move STERIS plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by STERIS plc executives and directors. Shares of STERIS plc have traded between $200.98 and $268.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming STERIS plc. STERIS plc is a $20.54B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming STERIS plc. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for STERIS plc. Coverage tracks STERIS plc within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BIIB — Biogen Inc.
  • DGX — Quest Diagnostics Incorporated
  • DXCM — DexCom, Inc.
  • LH — Labcorp Holdings Inc.
  • PHG — Koninklijke Philips N.V.
  • PODD — Insulet Corporation
  • SNN — Smith & Nephew plc
  • WAT — Waters Corporation

More Medical - Specialties companies

  • WOK — WORK Medical Technology Group Ltd.
  • YPHDF — Ypsomed Holding AG
  • ACAI — Safeplus International Holdings Limited
  • ADLI — American Medical Technologies Inc.
  • AIMV — AI Maverick Intel, Inc.
  • ALC — Alcon Inc.
  • ANIK — Anika Therapeutics, Inc.
  • APYX — Apyx Medical Corporation
  • ASFX — American Scientific Resources, Incorporated
  • AVTI — Avitar, Inc.
  • BEAT — HeartBeam, Inc.
  • BEATW — HeartBeam, Inc.

ETFs holding STERIS plc

  • IHI — iShares US Medical Devices ETF (3.14%)
  • CSMD — Congress SMID Growth ETF (2.17%)
  • SMCO — Hilton Small-MidCap Opportunity ETF (2.07%)
  • FEMD — First Eagle Mid Cap Equity ETF (1.94%)
  • POWA — Invesco Bloomberg Pricing Power ETF (1.91%)
  • MDEV — First Trust Indxx Medical Devices ETF (1.86%)
  • SAGP — Strategas Global Policy Opportunities ETF (1.65%)

News

Latest Market News